Comparative analysis of social issues toward medical abortion using mifepristone in South Korea and the United States: Topic modeling and sentiment analysis. [PDF]
PLoS OneKo M, Park DY, Oh JM, Song YK.
europepmc +1 more source
The efficacy of mifepristone-misoprostol regimen versus misoprostol-only for medication abortion at 22 + 0/7 to 30 + 0/7 weeks' gestation. [PDF]
Arch Gynecol ObstetTouval O +5 more
europepmc +1 more source
Cancer metastasis chemoprevention prevents circulating tumour cells from germination. [PDF]
Signal Transduct Target Ther, 2022 Xie X, Li Y, Lian S, Lu Y, Jia L.
europepmc +1 more source
Abortion Restrictions Threaten Miscarriage Management In The United States. [PDF]
Health Aff (Millwood)Nobles J, Hwang S, Bennett E, Jacques L.
europepmc +1 more source
Second-Trimester Induction Abortion Using Two Pretreatment Mifepristone Regimens: A Randomized Controlled Trial. [PDF]
CureusRajaraman V +4 more
europepmc +1 more source
Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic. [PDF]
Contraception, 2021 Chong E +17 more
europepmc +1 more source
Therapeutic Potential of Latin American Medicinal Plants in Oral Diseases: From Dental Pain to Periodontal Inflammation-A Systematic Review. [PDF]
Int J Mol SciRamírez-Torres V +4 more
europepmc +1 more source
What motivates primary care providers to prescribe mifepristone medication abortion? Results of a qualitative investigation in Canada. [PDF]
BMC Prim CareMunro S, Ennis M, Wahl K, Williams A.
europepmc +1 more source
Potential Uses of Adhatoda Vasica in Orthodontics.
J Pharm Bioallied Sci, 2023 Subramanian M +5 more
europepmc +1 more source
Trends in Abortion Rates in Ontario, Canada. [PDF]
JAMA Netw OpenSchummers L, Dunn S, Cheng L, Norman WV.
europepmc +1 more source